Morgan Stanley upgrades Gilead on HIV treatment growth
Go back to Morgan Stanley upgrades Gilead on HIV treatment growth| Gilead Sciences (NASDAQ: GILD) | Delayed: 148.07 +4.63 (3.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.44 | 52 Week High | $108.63 | |||
| Open | $145.10 | 52 Week Low | $71.39 | |||
| Day High | $148.97 | P/E | 81.81 | |||
| Day Low | $144.30 | EPS | $1.81 | |||
| Volume | 3,385,567 | |||||
| Morgan Stanley (NYSE: MS) | Delayed: 214.19 -3.36 (1.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $217.55 | 52 Week High | $39.88 | |||
| Open | $218.78 | 52 Week Low | $21.16 | |||
| Day High | $218.78 | P/E | 149.78 | |||
| Day Low | $213.69 | EPS | $1.43 | |||
| Volume | 2,593,308 | |||||
